NPR covered this, this morning.... http://www.npr.org/templates/story/story.php?storyId=124616398 In essence, the issue is that the Administration decided on a uniform policy for vetting ethics related to the original collection of the ESCs, etc. They decided not to grandfather any of the lines approved by Bush. Some of these appear like they might be eligible under the new standards, but the NIH won't approve them until their distributors supply the paperwork. It appears that some of the cell lines may not be eligible at all under the new law. The rub is that ESC research is dependent on the line being researched, and essentially becomes useless if the line becomes unavailable, meaning that millions of dollars in federal funding for ESC research in the past years may need to be redone or scrapped if the lines do not become available. It seems to be quite a mess... on the one hand, the Obama regulations seem like a good step towards normalizing the use of ESC lines. On the other hand, time and money is potentially going to be wasted, in a time when we don't have money to spare, if some of these popular lines do not become available again. Thoughts?